STEPHEN CAMPBELL: Open Payments
NPI 1801893524 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,670 in 102 payments from 23 companies in 2025. Trend: 2023 $1,116 · 2024 $1,951 · 2025 $1,670
Food & beverage: $1,670
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $247 |
| AstraZeneca Pharmaceuticals LP | 14 | $242 |
| Novo Nordisk Inc | 14 | $223 |
| PFIZER INC. | 10 | $179 |
| Indivior Inc. | 4 | $117 |
| Braeburn Inc. | 4 | $79 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| Lilly USA, LLC | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| Exact Sciences Corporation | 3 | $55 |
Products named: VRAYLAR, Ozempic, SUBLOCADE, NURTEC ODT, FARXIGA, Wegovy, BRIXADI, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
